PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
Progressive multifocal leukoencephalopathy (PML) is a deadly demyelinative disease of the CNS due to lytic infection of oligodendrocytes by the ubiquitous opportunistic polyoma virus JC(JCV). Most persons acquire this virus at a young age. After primary infection, it remains latent in the kidneys and lymphoid tissues for life. The virus is reactivated when cellular immunity is suppressed. Most PML cases occur in patients with AIDS, cancer and inflammatory disorders, and organ transplant recipients. Recently, PML has been reported in patients who had received natalizumab, a new drug for treatment of multiple sclerosis and Crohn's disease. The incidence of PML has increased due to the AIDS pandemic and the widespread use of immunosuppressive drugs. BK, a member of the same virus family, causes nephropathy in renal allografts, leading to graft loss.
Clinically, PML is characterized by a variety of neurologic deficits (visual loss, paralysis, dementia) evolving rapidly and causing death in a few months. The disease may get worse when the immune system is reconstituted after antiretroviral therapy. Rare cases of aseptic meningitis and JCV infection of cerebellar granular neurons causing ataxia have been reported. On magnetic resonance imaging (MRI), PML lesions are located in the subcortical white matter and are hyperintense on T2-weighted and FLAIR sequences. They show no contrast enhancement or mass effect. The CSF is either normal or shows a few lymphocytes.
![]() |
![]() |
| PML-myelin stain | PML-myelin stain |
![]() |
![]() |
![]() |
| PML-intranuclear inclusion | PML-atypical astrocytes | PML-viral particle in a nucleus |
In addition to its clinical significance, PML is interesting as a model of demyelination due to a lytic infection of myelin-producing cells. Neurotropic mouse hepatitis virus and canine distemper virus are animal models of virus-induced demyelination, similar to PML.
Further reading: Koralnik I J. Progressive Multifocal Leukoencephalopathy Revisited: Has the Disease Outgrown its Name? Ann Neurol 2006;60:162-173 PubMed
Updated: August, 2006





